BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,795,921 | +76.1% | 153,575 | +112.5% | 0.05% | +104.0% |
| Q2 2023 | $3,292,166 | -5.4% | 72,260 | -15.7% | 0.02% | -26.5% |
| Q1 2023 | $3,478,344 | +11.7% | 85,758 | +40.3% | 0.03% | +9.7% |
| Q4 2022 | $3,114,930 | +387.5% | 61,113 | +641.8% | 0.03% | +416.7% |
| Q1 2022 | $639,000 | -88.6% | 8,238 | -87.4% | 0.01% | -88.0% |
| Q4 2021 | $5,610,000 | +65.6% | 65,349 | +55.1% | 0.05% | +16.3% |
| Q3 2021 | $3,388,000 | +1.5% | 42,129 | +1.6% | 0.04% | -18.9% |
| Q2 2021 | $3,337,000 | +17.7% | 41,459 | +23.4% | 0.05% | -10.2% |
| Q1 2021 | $2,834,000 | +3.4% | 33,602 | -1.7% | 0.06% | -3.3% |
| Q4 2020 | $2,742,000 | -88.2% | 34,175 | -88.2% | 0.06% | -93.6% |
| Q3 2020 | $23,288,000 | +3423.1% | 289,580 | +3670.6% | 0.96% | +3325.0% |
| Q2 2020 | $661,000 | -3.6% | 7,680 | -6.4% | 0.03% | +33.3% |
| Q4 2019 | $686,000 | -33.3% | 8,209 | -30.2% | 0.02% | -19.2% |
| Q3 2019 | $1,029,000 | +56.1% | 11,760 | +46.1% | 0.03% | +136.4% |
| Q2 2019 | $659,000 | -87.1% | 8,051 | -87.2% | 0.01% | -90.0% |
| Q1 2019 | $5,105,000 | +18.3% | 62,783 | -4.2% | 0.11% | +18.3% |
| Q4 2018 | $4,314,000 | +598.1% | 65,542 | +718.0% | 0.09% | +745.5% |
| Q3 2018 | $618,000 | -76.6% | 8,012 | -77.6% | 0.01% | -78.0% |
| Q2 2018 | $2,639,000 | -34.8% | 35,740 | -42.6% | 0.05% | -31.5% |
| Q1 2018 | $4,050,000 | -2.7% | 62,265 | -3.3% | 0.07% | +5.8% |
| Q4 2017 | $4,161,000 | +74.1% | 64,373 | +69.0% | 0.07% | +50.0% |
| Q3 2017 | $2,390,000 | -33.1% | 38,095 | -35.5% | 0.05% | -32.4% |
| Q2 2017 | $3,573,000 | +169.7% | 59,020 | +130.9% | 0.07% | +183.3% |
| Q1 2017 | $1,325,000 | +0.1% | 25,558 | -14.6% | 0.02% | -4.0% |
| Q4 2016 | $1,324,000 | +118.1% | 29,924 | +131.3% | 0.02% | +257.1% |
| Q3 2016 | $607,000 | -14.5% | 12,937 | -17.6% | 0.01% | -30.0% |
| Q2 2016 | $710,000 | +34.7% | 15,696 | +22.3% | 0.01% | +42.9% |
| Q1 2016 | $527,000 | -98.3% | 12,833 | -98.4% | 0.01% | -96.2% |
| Q4 2015 | $30,638,000 | +15.9% | 803,099 | -0.2% | 0.18% | +0.5% |
| Q3 2015 | $26,434,000 | -41.3% | 804,935 | +24.9% | 0.18% | -25.0% |
| Q2 2015 | $45,040,000 | -3.5% | 644,271 | -5.5% | 0.24% | +4.3% |
| Q1 2015 | $46,675,000 | +2.9% | 681,491 | +10.1% | 0.23% | +9.9% |
| Q4 2014 | $45,358,000 | +5.9% | 618,973 | +3.7% | 0.21% | -14.5% |
| Q3 2014 | $42,832,000 | +7.6% | 596,971 | +8.4% | 0.25% | +23.9% |
| Q2 2014 | $39,808,000 | -5.2% | 550,671 | -3.5% | 0.20% | -9.5% |
| Q1 2014 | $41,990,000 | -29.7% | 570,674 | -33.6% | 0.22% | -26.2% |
| Q4 2013 | $59,736,000 | +561.2% | 858,903 | +524.7% | 0.30% | +568.9% |
| Q3 2013 | $9,035,000 | -13.6% | 137,500 | -8.9% | 0.04% | -18.2% |
| Q2 2013 | $10,461,000 | +828.2% | 151,000 | +873.5% | 0.06% | +243.8% |
| Q1 2013 | $1,127,000 | – | 15,511 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |